Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs72811465 | chr2:61468197 | T/C | 6.95E-5 | 177 | 23.43 | 30.93 | 10.3 | KM Plot |
PCPG | rs72811469 | chr2:61471018 | A/C | 6.7E-5 | 177 | 23.77 | 31.48 | 10.3 | KM Plot |
PCPG | rs72811492 | chr2:61499535 | G/A | 8.86E-5 | 173 | 20.47 | 30.93 | 10.3 | KM Plot |
PCPG | rs72813503 | chr2:61511819 | C/T | 8.71E-5 | 174 | 21.95 | 30.93 | 10.3 | KM Plot |
PCPG | rs72813521 | chr2:61526823 | C/A | 7.21E-5 | 176 | 23.77 | 30.93 | 10.3 | KM Plot |
PCPG | rs72813527 | chr2:61538239 | G/A | 6.82E-5 | 177 | 23.77 | 29.88 | 10.3 | KM Plot |
PCPG | rs72813528 | chr2:61540302 | C/G | 6.57E-5 | 177 | 24.1 | 29.43 | 10.3 | KM Plot |
PCPG | rs72813533 | chr2:61547975 | T/C | 0.000479 | 177 | 24.1 | 30.73 | 17.85 | KM Plot |
PCPG | rs72813537 | chr2:61552336 | A/G | 0.000478 | 178 | 23.43 | 30.33 | 17.85 | KM Plot |
PCPG | rs72813541 | chr2:61557082 | T/C | 0.000452 | 178 | 24.1 | 30.93 | 17.85 | KM Plot |
PCPG | rs72813555 | chr2:61574358 | A/G | 0.000478 | 178 | 23.43 | 30.33 | 17.85 | KM Plot |
PCPG | rs72813556 | chr2:61579592 | T/C | 6.43E-5 | 178 | 23.43 | 29.88 | 10.3 | KM Plot |
PCPG | rs72813558 | chr2:61582603 | A/G | 6.95E-5 | 177 | 23.43 | 29.43 | 10.3 | KM Plot |
PCPG | rs72813566 | chr2:61592737 | A/G | 6.81E-5 | 177 | 23.43 | 30.33 | 10.3 | KM Plot |
PCPG | rs72813567 | chr2:61594041 | A/C | 6.44E-5 | 177 | 24.1 | 30.93 | 10.3 | KM Plot |